| Literature DB >> 23623159 |
Elisa Civardi1, Chryssoula Tzialla, Fausto Baldanti, Luisa Strocchio, Paolo Manzoni, Mauro Stronati.
Abstract
BACKGROUND: Nosocomial infection is among the most important causes of morbidity, prolonged hospital stay, increased hospital costs, and mortality in neonates, particularly those born preterm. The vast majority of scientific articles dealing with nosocomial infections address bacterial or fungal infections, and viral agents are often disregarded. This analysis reviews the medical literature in an effort to establish the incidence, types of pathogens, and clinical features of noncongenital neonatal viral infections.Entities:
Keywords: Neonate; Noncongenital infection; Nosocomial infection; Virus
Mesh:
Year: 2013 PMID: 23623159 PMCID: PMC7132694 DOI: 10.1016/j.ajic.2013.01.026
Source DB: PubMed Journal: Am J Infect Control ISSN: 0196-6553 Impact factor: 2.918
Infection types in outbreaks
| Infection type | Number of outbreaks (total = 64) | % of total viral outbreaks |
|---|---|---|
| Gastrointestinal system infection (including hepatitis) | 35 | 54.69 |
| Lower respiratory tract infection other than pneumonia | 22 | 34.38 |
| Pneumonia | 10 | 15.63 |
| Eye, ear, nose, throat, or mouth infection | 9 | 14.06 |
| Systemic infection | 8 | 12.50 |
| Central nervous system infection | 6 | 9.38 |
| Bloodstream infection/sepsis | 4 | 6.25 |
| Skin and soft tissue infection | 0 | 0.00 |
| Unknown location | 1 | 1.56 |
Source of outbreaks
| Source of viral outbreaks | Outbreaks (total = 64) | % of total viral outbreaks |
|---|---|---|
| Patient (index case) | 32 | 50.00 |
| Personnel | 5 | 7.81 |
| Blood | 4 | 6.25 |
| Medical device | 1 | 1.56 |
| Parents | 0 | 0.00 |
| Unknown | 26 | 40.63 |
Number of involved individuals and mortality stratified by pathogens
| Pathogens | Number of outbreaks | % of total viral outbreaks | Number of patients involved | Average of patients | Number of staff involved | Number of deaths | Mortality, % |
|---|---|---|---|---|---|---|---|
| Rotavirus | 15 | 23.44 | 955 | 63.7 | 2 | 1 | 0.5 |
| Respiratory syncytial virus | 11 | 17.19 | 89 | 8.1 | 0 | 12 | 13.5 |
| Enterovirus | 10 | 15.63 | 101 | 10.1 | 4 | 5 | 4.9 |
| Hepatitis A | 7 | 10.94 | 48 | 6.9 | 84 | 0 | 0 |
| Adenovirus | 6 | 9.38 | 79 | 13.2 | 28 | 17 | 35.4 |
| Norovirus | 4 | 6.25 | 53 | 13.2 | 1 | 4 | 7.5 |
| Influenza A virus | 4 | 6.25 | 58 | 14.5 | 19 | 4 | 6.9 |
| Astrovirus | 3 | 4.69 | 101 | 33.7 | 1 | 0 | 0 |
| Parainfluenza virus | 3 | 4.69 | 22 | 7.3 | 16 | 2 | 9 |
| Coronavirus | 1 | 1.56 | 54 | 54 | 0 | 3 | 5.6 |
| Total | 64 | — | 1560 | — | 155 | 48 | — |
Measures to stop outbreaks
| Measure | Number of outbreaks (total = 64) | % of total viral outbreaks |
|---|---|---|
| Patient screening/surveillance | 44 | 68.75 |
| Isolation/cohorting | 34 | 53.13 |
| Handwashing/hand disinfection | 27 | 42.19 |
| Protective clothing | 26 | 40.63 |
| Personnel screening/surveillance | 23 | 35.94 |
| Modification of care/equipment | 20 | 31.25 |
| Closure of affected location | 17 | 26.56 |
| Disinfection/sterilization | 17 | 26.56 |
| Vaccination | 11 | 17.19 |
| (Change) antibiotic therapy | 9 | 14.06 |
| Personnel training | 4 | 6.25 |
| Restriction of workload | 3 | 4.69 |
| No measure | 1 | 1.56 |
| Not mentioned | 6 | 9.38 |